Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;5(12):2323-8.
doi: 10.2215/CJN.04220510. Epub 2010 Sep 16.

Cost-related immunosuppressive medication nonadherence among kidney transplant recipients

Roger W Evans  1 , William H Applegate, David M Briscoe, David J Cohen, Christopher C Rorick, Barbara T Murphy, Joren C Madsen
Affiliations

Cost-related immunosuppressive medication nonadherence among kidney transplant recipients

Roger W Evans et al. Clin J Am Soc Nephrol. 2010 Dec.

Abstract

Background and objectives: Immunosuppressive medications are essential in preventing kidney transplant rejection. Continuous insurance coverage for outpatient immunosuppressive medications remains a major issue. The objective of this study was to establish the prevalence and consequences of cost-related immunosuppressive medication nonadherence.

Design, setting, participants, & measurements: A descriptive survey of all U.S. kidney transplant programs (n = 254) was conducted. The response rate for the survey exceeded 99%. The main outcome measures included the following: transplant recipient concerns related to medication costs, ability to pay for medications, medication nonadherence and its consequences, and failure of transplant centers to place patients on the transplant waiting list.

Results: Continuous insurance coverage for outpatient immunosuppressive drugs is a problem having potentially grave consequences for the majority of kidney transplant recipients. More than 70% of kidney transplant programs report that their patients have an extremely or very serious problem paying for their medications. About 47% of the programs indicate that more than 40% of their patients are having difficulty paying for their immunosuppressive medications. In turn, 68% of the programs report deaths and graft losses attributable to cost-related immunosuppressive medication nonadherence. Some of the problems identified here are more significant for adult than pediatric patients.

Conclusions: The prevalence and consequences of cost-related immunosuppressive medication nonadherence among kidney transplant recipients have now been documented. The results presented here should serve as the necessary impetus for the development of health care policies supporting Medicare coverage of immunosuppressive medications for the life of the transplanted kidney.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Causes, correlates, and consequences of cost-related immunosuppressive medication nonadherence.
See this image and copyright information in PMC

References

    1. Task Force on Organ Transplantation: Report to the Secretary and the Congress on Immunosuppressive Therapies. Rockville, MD, Office of Organ Transplantation, Health Resources and Services Administration, Department of Health and Human Services, October 1985
    1. Task Force on Organ Transplantation: Organ Transplantation: Issues and Recommendations. Rockville, MD, Office of Organ Transplantation, Health Resources and Services Administration, Department of Health and Human Services, April 1986
    1. Kolata G: Drug transforms transplant medicine. Science 221: 40–42, 1983 - PubMed
    1. Macek C: Cyclosporine's acceptance heralds new era in immunpharmacology. JAMA 250: 449–455, 1983 - PubMed
    1. Evans RW: Kidney transplantation and cyclosporine. N Engl J Med 311: 127, 1984 - PubMed

Substances